Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis

被引：0
作者：
Shameek K. Gayen
Mary Zulty
Gerard J. Criner
机构：
[1] Lewis Katz School of Medicine at Temple University Hospital,Department of Thoracic Medicine and Surgery
来源：
Respiratory Research | / 25卷
关键词：
COPD; Pulmonary hypertension; Lung transplant; Pulmonary vascular resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Comorbidities and mortality among patients with chronic obstructive pulmonary disease
    Skajaa, Nils
    Laugesen, Kristina
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [22] Evaluation of exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension
    Mohamed, Ashraf
    Shaaban, Lamiaa
    Abdalah, Amira
    Tohamy, Ali
    Khaleel, Waleed
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2024, 73 (01):
  • [23] The prevalence of right to left shunt in chronic obstructive pulmonary disease patients with increased pulmonary hypertension
    Nouri, Maryam Nabavi
    Rouhani, Mohammad
    Mousavi, Seyed Ali Javad
    Shahmiri, Shahab Shahabi
    Mostafapour, Elyas
    Yahyazadeh, Houman
    Baradaran, Hamid Reza
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2010, 1 (02) : 67 - 71
  • [24] Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease
    Dahl, M
    Tybjærg-Hansen, A
    Vestbo, J
    Lange, P
    Nordestgaard, BG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (06) : 1008 - 1011
  • [25] Pulmonary vascular resistance determines mortality in end-stage renal disease patients with pulmonary hypertension
    Wolfe, Jonathan D.
    Hickey, Gavin W.
    Althouse, Andrew D.
    Sharbaugh, Michael S.
    Kliner, Dustin E.
    Mathier, Michael A.
    Wu, Christine M.
    Tevar, Amit D.
    Soman, Prem
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [26] Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis
    Wang, Guizuo
    Shang, Wenli
    Ren, Yajuan
    Liu, Sining
    Ren, Xiaoping
    Wei, Shenghong
    Han, Dong
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 70 : 39 - 42
  • [27] Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
    Park, Hye Yun
    Kang, Danbee
    Shin, Sun Hye
    Choi, Hayoung
    Jang, Seung Hun
    Lee, Chang-Hoon
    Kim, Hojoong
    Kwon, O. Jung
    Rhee, Chin Kook
    Cho, Juhee
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (04) : 640 - 648
  • [28] Risk Factors Associated with Development of Pulmonary Arterial Hypertension and Corpulmonale in Patients with Chronic Obstructive Pulmonary Disease
    Chaya, S. K.
    Mahendra, M.
    Thippeswamy, T.
    Jayaraj, B. S.
    Lokesh, K. S.
    Mahesh, P. A.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (04) : 289 - 298
  • [29] Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data
    Tracey J. Weiss
    Dena Rosen Ramey
    Lingfeng Yang
    Xinyue Liu
    Mahesh J. Patel
    Swapnil Rajpathak
    Ednan K. Bajwa
    Dominik Lautsch
    BMC Pulmonary Medicine, 22
  • [30] Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
    Calancea, Valentin
    Dumitras, Tatiana
    Ghicavii, Nelea
    Barba, Doina
    Fetco-Mereuta, Diana
    Matcovschi, Sergiu
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345